LivaNova PLC
LIVN
Hisse Senetlerindeki Sıralama
#3783
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Hisse Fiyatı
$80.35
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$4.41B
Değişim (1 gün)
2.83%
Değişim (1 yıl)
46.87%
Ülke
GB
Ticaret LivaNova PLC (LIVN)
Kategori
Healthcare
LivaNova PLC (LIVN) için P/S oranı
October 2026 itibarıyla P/S oranı TTM: 2.84
LivaNova PLC şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 2.84'dir. 2023 yılının sonunda şirketin P/S oranı 2.42 idi.
LivaNova PLC için P/S oranı geçmişi 2000 - 2026 arası
Her yılın sonunda P/S oranı
| Yıl | P/S Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 2.84 | 42.01% |
| 2024 | 2.00 | -17.11% |
| 2023 | 2.42 | -16.82% |
| 2022 | 2.91 | -32.02% |
| 2021 | 4.28 | 24.15% |
| 2020 | 3.44 | 2.38% |
| 2019 | 3.36 | -16.06% |
| 2018 | 4.01 | 5.30% |
| 2017 | 3.81 | 110.23% |
| 2016 | 1.81 | -66.32% |
| 2015 | 5.37 | -29.20% |
| 2013 | 7.59 | -14.77% |
| 2012 | 8.91 | -13.53% |
| 2011 | 10.30 | -10.81% |
| 2010 | 11.55 | -10.97% |
| 2009 | 12.97 | -15.16% |
| 2008 | 15.29 | 12.20% |
| 2007 | 13.62 | -3.49% |
| 2006 | 14.12 | -13.13% |
| 2005 | 16.25 | 11.43% |
| 2004 | 14.58 | -1.13% |
| 2003 | 14.75 | -31.71% |
| 2002 | 21.60 | 0.00% |
| 2001 | 0.00 | -100.00% |
| 2000 | 26.35 | 0.00% |
Benzer şirketler veya rakipler için P/S oranı
| Şirket | P/S Oranı | P/S Oranı Farkı | Ülke |
|---|---|---|---|
| 3.82 | 34.67% |
US
|
|
| 2.78 | -1.95% |
IE
|
|
| 4.18 | 47.13% |
US
|
|
| 2.97 | 4.58% |
US
|
|
| - | - |
DE
|
